Varying the intensity of cystoscopic surveillance for high‐risk non‐muscle‐invasive bladder cancer
In microsimulations testing a wide range of cystoscopic surveillance intensity for patients newly diagnosed with HRNMIBC, moderate surveillance de-escalation appears associated with an insignificant change in 10-year OS and furthermore is cost-effective vs higher-intensity surveillance regimens. These results suggest that moderate surveillance de-escalation can reduce costs of care without compromising life expectancy for many patients.
Authors
- Sunil Patel (ORCID: https://orcid.org/0000-0002-5045-0152)
- Michael E. Rezaee (ORCID: https://orcid.org/0000-0002-6236-8682)
- Nirmish Singla (ORCID: https://orcid.org/0000-0001-9495-6983)
- Taibo Li (ORCID: https://orcid.org/0000-0002-6624-9293)
- Isabella Florissi (ORCID: https://orcid.org/0000-0002-4401-8427)
- Zhuo T. Su (ORCID: https://orcid.org/0000-0003-3215-6192)
- Jeffrey P. Townsend (ORCID: https://orcid.org/0000-0002-9890-3907)
- Max Kates (ORCID: https://orcid.org/0000-0003-1166-7225)
- Katherine Mahon
Institutions
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- Yale University (US)
Publication Details
- Journal
- British Journal of Urology
- Published
- 2024-08-29
- DOI
- https://doi.org/10.1111/bju.16521
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00